Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Propensity Score Matching Analysis Demonstrates the Use of Statin Enhances Chance of Achieving MR4.5 in Chronic Myeloid Leukemia Patients in Chronic Phase Following Imatinib Therapy Regardless of Other Clinical Features Including Age of the Patients

Dennis Dong Hwan Kim, MDPhD, Feras Alfraih, MD, Tanya Adityan, Jeffrey H. Lipton, MD PhD

Blood (2015) 126 (23): 4026.

https://doi.org/10.1182/blood.V126.23.4026.4026

Published: 2015

Journal Articles

Risk Factor Analysis for the Development of Large Granular Lymphocytosis after Allogeneic Hematopoietic Cell Transplantation: Randomized Stratification and Propensity Score Analysis

Marc Poch Martell, MD, Elizabeth Shin, Jieun Uhm, MD, Fotios V. Michelis, MDPhD, Auro Viswabandya, MD DM, Jeffrey H. Lipton, MD PhD, Hans A. Messner, MD/PhD, Dennis Dong Hwan Kim, MDPhD

Blood (2015) 126 (23): 1945.

https://doi.org/10.1182/blood.V126.23.1945.1945

Published: 2015

Journal Articles

Predictors of the Trajectory of Neurocognitive Functioning in the First Six Months after Allogeneic Hematopoietic Stem Cell Transplantation

Samantha J Mayo, RN, PhD, Hans A. Messner, MD/PhD, Sean B. Rourke, PhD, Doris Howell, RN PhD, J. Charles Victor, John Kuruvilla, MD, Jeffrey H. Lipton, MD PhD, Vikas Gupta, MD MRCP, FRCPath, Dennis Dong Hwan Kim, MDPhD, Laura McGillis, BScN, MN, RN(EC), CONc, Jieun Uhm, MD, Fotios V. Michelis, MDPhD, Naheed Alam, MBBS,MD, Anna Lambie, RN NP, Dawn Breen, RN, David Loach, MD, Christine Piescic, RN, Kelly Metcalfe, RN PhD

Blood (2015) 126 (23): 3289.

https://doi.org/10.1182/blood.V126.23.3289.3289

Published: 2015

Journal Articles

Analysis of Impact of Comorbidities Constituting the HCT-CI Score on the Outcome of Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia

Fotios V. Michelis, MDPhD, Hans A. Messner, MD/PhD, Naheed Alam, MBBS,MD, Vikas Gupta, MD MRCP, FRCPath, Dennis Dong Hwan Kim, MDPhD, John Kuruvilla, MD, Anna Lambie, RN NP, Auro Viswabandya, MD DM, Jeffrey H. Lipton, MD PhD

Blood (2015) 126 (23): 3201.

https://doi.org/10.1182/blood.V126.23.3201.3201

Published: 2015

Journal Articles

Retrospective Analysis of Allogeneic Transplant Outcomes in Chronic Myeloid Leukemia Patients with Tyrosine Kinase Inhibitors Failure

Dennis Dong Hwan Kim, MDPhD, Isabelle Bence-Bruckler, MD FRCPC, Christopher M. Hillis, MD FRCPC, Irwin Walker, MBBS, Suzanne Kamel-Reid, PhD, Jeffrey H. Lipton, MD PhD

Blood (2014) 124 (21): 4554.

https://doi.org/10.1182/blood.V124.21.4554.4554

Published: 2014

Journal Articles

The Use of Statin Enhances Chance of Achieving MR4.5 in Chronic Myeloid Leukemia Patients in Chronic Phase Following Imatinib Therapy

Dennis Dong Hwan Kim, MDPhD, Feras Alfraih, MD, Honggi Lee, MD, Jeffrey H. Lipton, MD PhD

Blood (2014) 124 (21): 1804.

https://doi.org/10.1182/blood.V124.21.1804.1804

Published: 2014

Journal Articles

An Adverse Prognostic Effect of Homozygous TET2 Mutational Status on the Relapse Risk of Acute Myeloid Leukemia Patients of Normal Karyotype

Jae-Sook Ahn, MDPhD, Hyeoung-Joon Kim, MD PhD, Yeo-Kyeoung Kim, MD, PhD, Il-Kwon Lee, PhD, Nan Young Kim, Mark D Minden, MDPhD, Chul Won Jung, MD PhD, Jun-Ho Jang, MD PhD, Hee-Je Kim, Joon Ho Moon, MD, PhD, Sang Kyun Sohn, MD PhD, Jong-Ho Won, Sung-Hyun Kim, MD PhD, Namshin Kim, PhD, Kenichi Yoshida, MD PhD, Seishi Ogawa, MD PhD, Dennis Dong Hwan Kim, MDPhD

Blood (2014) 124 (21): 1052.

https://doi.org/10.1182/blood.V124.21.1052.1052

Published: 2014

Journal Articles

Multiple CMV Reactivations Are Associated with Lower Risk of Relapse Following Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation

Feras Alfraih, MD, Naheed Alam, MBBS,MD, Vikas Gupta, MD FRCP, FRCPath, Dennis Dong Hwan Kim, MDPhD, John Kuruvilla, MD, Jeffrey H. Lipton, MD PhD, David Loach, MD, Matthew D. Seftel, MRCP, FRCPC, MPH, Jieun Uhm, MD, Anna Lambie, NP, Hans A. Messner, PhD

Blood (2014) 124 (21): 3955.

https://doi.org/10.1182/blood.V124.21.3955.3955

Published: 2014

Journal Articles

Propensity Score Matching Analysis Comparing Reduced Intensity Versus Myeloablative Conditioning in AML/MDS Patients Transplanted with Fludarabine-Busulfan-Low Dose Total Body Irradiation Based Regimen

Hassan Sibai, Fotios V. Michelis, MDPhD, Nada Hamad, MBBS Hons, FRACP, FRCPA, Jieun Uhm, MD, Vikas Gupta, MD MRCP, MRCPath, John G. Kuruvilla, MD, Jeffrey H. Lipton, MD PhD, Hans A. Messner, PhD, Matthew D. Seftel, MBChB, FRCP(C), MRCP, Dennis Dong Hwan Kim, MDPhD

Blood (2014) 124 (21): 3870.

https://doi.org/10.1182/blood.V124.21.3870.3870

Published: 2014

Journal Articles

A Risk Score to Predict CMV Viremia within the First 100 Days after Allogeneic Stem Cell Transplantation Based on Pre-Transplant Parameters

Feras Alfraih, MD, John Kuruvilla, MD, Naheed Alam, MBBS,MD, Anna Lambie, NP, Vikas Gupta, MD FRCP, FRCPath, Dennis Dong Hwan Kim, MDPhD, Matthew D. Seftel, MRCP, FRCPC, MPH, Jieun Uhm, MD, David Loach, MD, Eshetu G Atenafu, M.Sc., Jeffrey H. Lipton, MD PhD, Hans A. Messner, MD PhD

Blood (2014) 124 (21): 3877.

https://doi.org/10.1182/blood.V124.21.3877.3877

Published: 2014

Journal Articles

Clinical Characteristics, Risk Factors and Outcomes of CMV Disease after Allogeneic Stem Cell Transplantation

Feras Alfraih, MD, Naheed Alam, MBBS,MD, Anna Lambie, NP, Vikas Gupta, MD FRCP, FRCPath, Dennis Dong Hwan Kim, MDPhD, John Kuruvilla, MD, Jeffrey H. Lipton, MD PhD, Matthew D. Seftel, MRCP, FRCPC, MPH, Jieun Uhm, MD, David Loach, MD, Hans A. Messner, MD PhD

Blood (2014) 124 (21): 3879.

https://doi.org/10.1182/blood.V124.21.3879.3879

Published: 2014

NARROW

Propensity Score Matching Analysis Demonstrates the Use of Statin Enhances Chance of Achieving MR4.5 in Chronic Myeloid Leukemia Patients in Chronic Phase Following Imatinib Therapy Regardless of Other Clinical Features Including Age of the Patients

Risk Factor Analysis for the Development of Large Granular Lymphocytosis after Allogeneic Hematopoietic Cell Transplantation: Randomized Stratification and Propensity Score Analysis

Predictors of the Trajectory of Neurocognitive Functioning in the First Six Months after Allogeneic Hematopoietic Stem Cell Transplantation

Analysis of Impact of Comorbidities Constituting the HCT-CI Score on the Outcome of Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia

Retrospective Analysis of Allogeneic Transplant Outcomes in Chronic Myeloid Leukemia Patients with Tyrosine Kinase Inhibitors Failure

The Use of Statin Enhances Chance of Achieving MR4.5 in Chronic Myeloid Leukemia Patients in Chronic Phase Following Imatinib Therapy

An Adverse Prognostic Effect of Homozygous TET2 Mutational Status on the Relapse Risk of Acute Myeloid Leukemia Patients of Normal Karyotype

Multiple CMV Reactivations Are Associated with Lower Risk of Relapse Following Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation

Propensity Score Matching Analysis Comparing Reduced Intensity Versus Myeloablative Conditioning in AML/MDS Patients Transplanted with Fludarabine-Busulfan-Low Dose Total Body Irradiation Based Regimen

A Risk Score to Predict CMV Viremia within the First 100 Days after Allogeneic Stem Cell Transplantation Based on Pre-Transplant Parameters

Clinical Characteristics, Risk Factors and Outcomes of CMV Disease after Allogeneic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only